Français

English

العربية

+38 067 935 25 44

00380689869898 (汉语)

00380930552240 (باللغة العربية)

infocenter@emcell.com

+38 067 935 25 44

infocenter@emcell.com

Demande dinfos

Top traitements Traitement de l'autisme Traitement anti-âge Traitement des maladies du coeur Traitement de diabete Traitement de sclérose en plaques Traitement des dystrophies musculaires Anémie Amyotrophie spinale Arthrite rhumatoïde Cancer Colite ulcéreuse et maladie de Crohn Dysfonction érectile Hypertension artérielle Le traitement de Parkinson Maladie d’Alzheimer SLA/Maladie du neurone moteur

Top traitements Traitement de l\'autisme Traitement anti-âge Traitement des maladies du coeur Traitement de diabete Traitement de sclérose en plaques Traitement des dystrophies musculaires

See All

Anémie Amyotrophie spinale Arthrite rhumatoïde Cancer Colite ulcéreuse et maladie de Crohn Dysfonction érectile Hypertension artérielle Le traitement de Parkinson Maladie d’Alzheimer SLA/Maladie du neurone moteur

Hide

Site Menu

Our licences

Accueil →

Affections et maladies →

Cancer →

Demande dinfos

Tables

Table 1. The peripheral blood counts in patients with oncological and hematological disturbances after fetal stem cell transplantation
Table 2. Contents of leukocytes in peripheral blood after chemotherapy in hematological patients after fetal stem cells transplantation and in a control group
Table 3. Recovery of total leukocytes and neutrophyls in hematological patients with severe postchemotherapy neutropenia after fetal stem cells transplantation
Table 4. Peripheral blood indices in patients with cervical cancer after cell therapy (n=23)
Table 5. Immune indices in patients with cervical cancer after fetal stem cells transplantation
Table 6. Psychophysiological changes in cancer patients after the fetal stem cell transplantation

Table 1. The peripheral blood counts in patients with oncological and hematological disturbances after fetal stem cell transplantation (n=26)

Term of observation	Erythrocytes 10¹²/l M ± m	Hemoglobin g/l M ± m	Thrombocytes 10⁹/l M ± m	Leukocytes 10⁹/l M ± m
Before treatment	2.65 ± 0.15	78.19 ± 4.25	79.40 ± 16.42	1.37 ± 0.16
After FSCT (days)
3	2.72 ± 0.13	79.39 ± 3.91	133.20 ± 38.39	1.90 ± 0.31
5	2.75 ± 0.13	82.42 ± 3.51	191.92 ± 55.92	3.12 ± 1.05
7	2.87 ± 0.13	84.77 ± 3.52	153.34 ± 37.35	4.46 ± 1.78
11	3.12 ± 0.15	91.27 ± 3.54	164.23 ± 29.54	4.21 ± 0.69
13	3.40 ± 0.16	96.19 ± 3.50	212.65 ± 37.95	4.68 ± 0.89
30	3.51 ± 0.16	103.27 ± 3.67	163.73 ± 20.00	5.20 ± 1.01

Table 2. Contents of leukocytes in peripheral blood after chemotherapy in hematological patients after fetal stem cells transplantation (n=26) and in a control group (n=30)

Days after Transplantation	After Fetal Stem Cells Transplantation (n=26)					Control group (n=30)
	M	m	%	M	m	%
0	1.37	0.16	100	1.20	0.07	100
3	1.90	0.31	138	1.17	0.09	97.5
5	3.12	1.05	228	—	—	—
7	4.46	1.78	325	1.18	0.11	97.7
11	4.21	0.69	307	1.51	0.15	126
13	4.68	0.89	341	2.10	0.20	175
30	5.20	1.01	379	4.10	0.48	341

Table 3. Recovery of total leukocytes and neutrophyls in hematological patients with severe postchemotherapy neutropenia after fetal stem cells transplantation (n=16)

Days after transplantation	Total leukocytes					Neutrophils
	M	m	%	M	m	%
0	0.98	0.17	100	0.18	0.07	100
3	1.24	0.14	126	0.40	0.12	222
5	3.02	1.56	308	1.76	1.24	977
7	4.79	2.89	488	2.18	1,627
11	3.59	0.91	366	1.79	0.76	994
13	3.78	1.17	385	2.06	0.95	1,144
30	4.83	1.50	492	1.95	0.54	1,083

Table 4. Peripheral blood indices in patients with cervical cancer after cell therapy (n=23)

Blood indices	St.in	Before stem cell therapy	Days after cell therapy
Blood indices	St.in	Before stem cell therapy	3	7	11	15	30
Erythrocytes, 10¹²/l	M m p	3.60 0.11	3.54 0.19	3.59 0.16	3.62 0.17	4.05 0.21	3.89 0.19
Hemoglobin, G/l	M m p	111.4 6.0	106.3 5.25	109.9 5.08	111.5 4.79	115.8 4.53	120.7 4.33
Leukocytes, 10⁹/l	M m p	2.66 0.29	3.14 0.53	3.83 0.49 <0.05	3.53 0.52	3.36 0.28 <0.05	3.55 0.24 <0.01
Neutroph. stab, %	M m p	6.29 1.38	5.14 1.03	4.93 0.55	5.50 1.29	5.79 1.35	5.38 1.02
Neutroph. stab, G/l	M m p	180.9 34.1	154.6 41.6	190.7 30.3	269.0 115.3	198.4 46.3	199.8 44.8
Neutroph. segmented, %	M m p	54.3 2.56	58.6 2.73	58.7 2.38	64.1 2.57 <0.01	63.1 1.90 <0.005	64.7 2.54 <0.005
Neutrophils segm., 10⁹/l	M m p	1.48 0.20	1.84 0.31	2.29 0.33 <0.05	2.24 2.98 <0.05	2.04 0.16 <0.05	2.18 0.08 <0.05
Lymphocytes, %	M m p	20.6 2.06	20.9 2.31	23.1 1.80	17.2 1.62	18.6 1.95	15.7 1.93
Lymphocytes, 10⁹/l	M m p	0.55 0.07	0.75 0.22	0.89 0.18	0.59 0.09	0.63 0.10	0.48 0.06
Monocytes, %	M m p	8.21 0.86	9.29 1.15	9.64 1.04	8.50 1.47	7.14 1.03	8.23 1.27
Monocytes, 10⁹/l	M m p	0.21 0.02	0.27 0.04	0.34 0.04 0.05	0.32 0.08	0.23 0.03	0.27 0.05

Table 5. Immune indices in patients with cervical cancer after fetal stem cells transplantation

Immunological tests	Before FSCT		Two weeks after FSCT		After radiotherapy
	n=7		n=7		n=7
	M	m	M	m	M	m
Leukocytes, 10⁹/l	2.90	0.14	3.91	0.38	3.54	0.40
Lymphocytes, %	16.00	4.62	16.71	2.13	20.14	3.84
B-lymphocytes, (CD19+), %	13.96	1.64	10.21	1.33	11.00	0.63
B-lymphocytes, per mm³	66.34	23.74	68.02	15.5	70.76	8.75
T-lymphocytes, (CD3+), %	38.42	7.87	39.71	5.13	50.71	3.97
T-lymphocytes, per mm³	168.98	67.03	254.90	58.9	332.62	54.16
T-helpers (CD4+), %	25.46	5.76	27.14	3.62	33.59	2.40
T-helpers, mm³	112.11	47.36	177.90	44.9	220.12	34.76
T-suppressers (CD8+), %	12.31	2.66	15.08	1.56	18.86	2.01
T-suppressers, mm³	59.85	26.95	95.65	17.9	121.17	18.50
NK-cells (CD16+), %	17.30	2.63	21.94	6.04	15.56	1.90
NK-cells (CD16+), per mm³	84.55	32.98	129.87	34.3	95.01	8.79
CD4+/CD8+	2.03	0.36	1.70	0.11	1.77	0.09

Table 6. Psychophysiological changes in cancer patients after the fetal stem cell transplantation

75 clinical cases were analyzed: with cytostatic disease (50), without signs of cytostatic disease (25). Assessment of disorders of psychic condition, depressive symptoms, emotional changes, spirits, and changes of thinking, memory and intellect were carried out.

	Before FSCT	First 6–12 hours	1–3 days	5–10 days	3–6 weeks	3–6 months
State of spirit
Depression	+++	–	–	–	–	+
Composure, optimism	–	+	+	+	++	++
Desperation	+++	–	–	–	+	+
Tranquillity, hope	–	–	+	+	++	++
Emotional sphere
Self awareness	–	+	++	+	++	++
Activity	–	++	+	++	++	++
Anxiety	++	+	+	–	–	+
Stability of emotional state	–	+	+	++	++	++
Mental capacity
Attention (strength and stability of concentration),	+	++	+++	+	++	++
Improvement of thinking process, memory, creativity, decreasing of manifestations of senile dementia	+	+	++	++	+++	+++
Improvement of contact with doctors and people around	+	++	++	++	++	++
Improvement of quality of sleeping	–	+	++	++	++	+
Sexual energy	–	–	+	++	+	+

Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.

téléphone:	+38 044 223 28 95
Fax:	+38 044 468 80 29
portable:	+38 067 935 25 44

Our licences

Tables

EmCell Centre de Thérapie Cellulaire